NeoGenomics Non-GAAP EPS of $0.06 beats by $0.02, revenue of $190.17M beats by $1.89M
Source: SeekingAlpha
2026-02-17 07:08:32 ET
More on NeoGenomics
- NeoGenomics: Distribution Moat In Community Oncology
- NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- NeoGenomics Q4 2025 Earnings Preview
- NeoGenomics sees Q4 revenue of about $190M
Read the full article on Seeking Alpha
For further details see:
NeoGenomics Non-GAAP EPS of $0.06 beats by $0.02, revenue of $190.17M beats by $1.89M
NeoGenomics Inc.
NASDAQ: NEO
NEO Trading
-2.15% G/L:
$8.885 Last:
503,222 Volume:
$9.04 Open:
NEO Latest News
February 25, 2026 07:05:00 am
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
NEO Stock Data
$1,500,898,492
126,282,494
0.16%
88
N/A
Medical Diagnostics & Screening
Healthcare
US
Fort Myers
